New Perspectives in the Management of Acne, Photodamage, and Wound Healing
A supplement to Pediatric News supported by an unrestricted educational grant from OrthoNeutrogena.
This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Pediatric News. The articles contained within this supplement are based on clinical dialogues held with the faculty.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 11.
Contents
• Acne Vulgaris
• Photodamage and Photoaging
• Wound Healing After Cosmetic Procedures
• Striae Distensae
• Precautions About Sun Exposure
Faculty
Hilary E. Baldwin, MD
Associate Professor of Clinical Dermatology
Department of Dermatology
SUNY Downstate Medical Center
Brooklyn, N.Y. Speaker's Bureau: Allergan Inc., Connetics Pharmaceuticals, Dermik Laboratories, Galderma Laboratories, OrthoNeutrogena Corporation, Ranbaxy Pharmaceuticals, and Stiefel Laboratories.
Diane S. Berson, MD
Assistant Professor of Dermatology
Weill Medical College of Cornell University
New York, N.Y. Ad Hoc Advisory Boards: Allergan, Connetics, Dermik, Galderma, Medicis Pharmaceuticals Corporation, OrthoNeutrogena, Ranbaxy, and Stiefel.
Target Audience
This activity has been developed for dermatologists, pediatricians, and other healthcare professionals involved in the treatment of acne and photodamage.
Educational Needs
The retinoid class of topical agents—adapalene, tazarotene, and tretinoin—constitute the recommended first-line treatment for acne vulgaris. These agents may be used as monotherapy or in combination with topical antibiotics/antimicrobials; several combination products have been developed and are not marketed. In clinical trials, the topical retinoid tretinoin also has demonstrated benefits in mitigating the signs of photodamaged skin. It is possible that the other topical agents in this class would show similar benefits. Finally, recent clinical studies have shown that topical application of tretinoin prior to cosmetic procedures such as dermabrasion and chemical peels helps to speed healing and prevent scarring. Physicians who are in a position to use these agents and/or counsel patients about acne and photodamage must be aware of the risks and benefits of topical retinoid use.
Learning Objectives
By reading and studying this supplement, participants should be able to:
• understand acne pathogenesis and its implications for therapy.
• discuss the topical treatment options available to treat acne of various types and severity.
• identify the early signs of photodamage and photoaging in the skin.
• describe the therapies now available for attenuating the signs of photoaging.
• explain the benefits of pretreatment with topical retinoid therapy in cosmetic procedures such as laser resurfacing and chemical peels.
• recognize the role of topical retinoids in the treatment of acne, photoaging, and wound healing following cosmetic procedures.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Pediatric News. The EOCME is accredited by the ACCME to provide continuing medical education for physicians.
The EOCME designates this educational activity for a maximum of 1.5 AMA/PRA category 1 credits toward the American Medical Association (AMA) Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
